Evidence map›Paper›PMID 30776744›Full record

ReviewCurrent opinion in biotechnology2019

Ion channel engineering for modulation and de novo generation of electrical excitability.

Hung X Nguyen, Nenad Bursac

Abstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The function of chloride channels in digestive system disease (Review).International journal of molecular medicine · 2025
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hung X NguyenDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Nenad BursacDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Electronic address: nbursac@duke.edu.

Funding

Integrated Cellular and Tissue Engineering for Ischemic Heart DiseaseU01HL134764 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BURSAC, NENAD, KAMP, TIMOTHY J. · 2016 to 2022
$7.7M
In Vitro and In Situ Engineering of Fibroblasts for Cardiac RepairR01HL132389 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2016 to 2019
$2.0M
Engineering of Human Excitable Tissues from Unexcitable CellsR01HL126524 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2016 to 2019
$1.9M
Function and Integration of Stem Cell-derived Cardiac Tissue PatchR01HL104326 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2010 to 2014
$1.8M
Bioengineering a Living Tissue ConductorR21HL126193 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2015 to 2016
$437k
Cardiac Progenitor Patch for Treatment of Myocardial InfarctionR21HL095069 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2010 to 2011
$429k
NHLBI NIH HHS R01 HL104326NHLBI NIH HHS R01 HL126524NHLBI NIH HHS R01 HL132389NHLBI NIH HHS R21 HL095069NHLBI NIH HHS R21 HL126193NHLBI NIH HHS U01 HL134764
6 · The paper itself

Abstract

Ion channels play essential roles in regulating electrical properties of excitable tissues. By leveraging various ion channel gating mechanisms, scientists have developed a versatile set of genetically encoded tools to modulate intrinsic tissue excitability under different experimental settings. In this article, we will review how ion channels activated by voltage, light, small chemicals, stretch, and temperature have been customized to enable control of tissue excitability both in vitro and in vivo. Advantages and limitations of each of these ion channel-engineering platforms will be discussed and notable applications will be highlighted. Furthermore, we will describe recent progress on de novo generation of excitable tissues via expression of appropriate sets of engineered voltage-gated ion channels and discuss potential therapeutic implications.

Indexed as

Ion Channel GatingElectricityIon ChannelsIon Channels

Identifiers

PMID30776744
PMCPMC6697248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.